Protein misfolding in neurodegenerative diseases
- 4 May 2004
- journal article
- review article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 30 (3) , 215-224
Abstract
A common pathogenic mechanism shared by diverse neurodegenerative disorders, like Alzheimer's disease, Parkinson's disease, Huntington's disease and transmissible spongiform encephalopathies, may be altered protein homeostasis leading to protein misfolding and aggregation of a wide variety of different proteins in the form of insoluble fibrils. Mutations in the genes encoding protein constituents of these aggregates have been linked to the corresponding diseases, thus a reasonable scenario of pathogenesis was based on misfolding of a neurone‐specific protein that forms insoluble fibrils that subsequently kill neuronal cells. However, during the past 5 years accumulating evidence has revealed the neurotoxic role of prefibrillar intermediate forms (soluble oligomers and protofibrils) produced during fibril formation. Many think these may be the predominant neurotoxic species, whereas microscopically visible fibrillar aggregates may not be toxic. Large protein aggregates may rather be simply inactive, or even represent a protective state that sequesters and inactivates toxic oligomers and protofibrils. Further understanding of the biochemical mechanisms involved in protein misfolding and fibrillization may optimize the planning of common therapeutic approaches for neurodegenerative diseases, directed towards reversal of protein misfolding, blockade of protein oligomerization and interference with the action of toxic proteins.Keywords
This publication has 77 references indexed in Scilit:
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Molecular Chaperones in the Cytosol: from Nascent Chain to Folded ProteinScience, 2002
- Impairment of the Ubiquitin-Proteasome System by Protein AggregationScience, 2001
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Themes and variations on ubiquitylationNature Reviews Molecular Cell Biology, 2001
- Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapyProceedings of the National Academy of Sciences, 2000
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1999
- Amyloid diseases: Abnormal protein aggregation in neurodegenerationProceedings of the National Academy of Sciences, 1999
- Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and diseaseProceedings of the National Academy of Sciences, 1999
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1997